Clinical Trial Update: A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates potential drug-drug interactions by assessing how pelabresib affects the pharmacokinetics of repaglinide, midazolam, and a combined…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Combined oral contraceptive
• Midazolam (Midazolam)
• Pelabresib (pelabresib)
• Repaglinide (Repaglinide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Malignancies | Phase 1 | Status: NOT_YET_RECRUITING